Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.64 +1.28%

+$0.16 today

Market cap
$143.23M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.22M

Average 0.35M

RNA Other Working Capital

Cash effect of changes in other operating assets and liabilities.

Atrium Therapeutics, Inc.NASDAQ: RNA

Other Working Capital · Q1 FY2026 · quarter ended Mar 2026

Other working capital of -$9.12M in Q1 FY2026

Q1 FY2026 other working capital was -$9.12M.

Context

  • Other working capital amounted to 21.1% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$9.12M-567.7% QoQ
Last fiscal yearDec 2025
-$3.93M— YoY
Other Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Working Capital history

USD · from the cash flow

Latest · FY2025
(3.93M) USD
Year-over-year change
—

Other Working Capital vs competitors

How RNA compares with its peers on the latest reported figures

No competitor Other Working Capital figures are available to compare.

Atrium Therapeutics, Inc.

NASDAQ:RNA

Intrinsic Alpha fair value

Locked

Current Price

$6.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.